{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:31Z","timestamp":1792712431791,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.atherosclerosis.2006.11.006","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T18:01:58Z","timestamp":1165514518000},"page":"348-356","source":"Crossref","is-referenced-by-count":46,"title":["Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model"],"prefix":"10.1016","volume":"194","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0092-8674(91)90279-8","article-title":"Leukocyte\u2013endothelial cell recognition: three (or more) steps to specificity and diversity","volume":"67","author":"Butcher","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/physrev.1999.79.1.181","article-title":"Mechanisms that regulate the function of the selectins and their ligands","volume":"79","author":"Vestweber","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib6","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.101.19.2290","article-title":"Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice","volume":"101","author":"Dong","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.191.1.189","article-title":"P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice","volume":"191","author":"Collins","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.103.7.1000","article-title":"Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice","volume":"103","author":"Manka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","article-title":"Soluble P-selectin and the risk of future cardiovascular events","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib10","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","article-title":"A major role for VCAM-1, but not ICAM-1, in early atherosclerosis","volume":"107","author":"Cybulsky","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9150(01)00587-1","article-title":"Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice","volume":"160","author":"Kitagawa","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.18-1-65","article-title":"The role of MCP-1 in atherosclerosis","volume":"18","author":"Harrington","year":"2000","journal-title":"Stem Cells"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI5624","article-title":"MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B","volume":"103","author":"Gosling","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tcm.2004.02.006","article-title":"Modulation of atherogenesis by chemokines","volume":"14","author":"Boisvert","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2003.12.024","article-title":"3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes","volume":"175","author":"Blum","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9149(02)02383-4","article-title":"Aspirin beyond platelet inhibition","volume":"90","author":"Verheugt","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib17","first-page":"120","article-title":"Pharmacology of HMG CoA reductase inhibitors (statins)","volume":"149","author":"Kostner","year":"1999","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib18","series-title":"Atherosclerosis X","article-title":"Rabbit models of atherosclerosis and restenosis","author":"Caplice","year":"1995"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib19","series-title":"Cecil textbook of medicine","first-page":"111","year":"1996"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/01.CIR.103.12.1688","article-title":"Aspirin (5mmol\/l) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model","volume":"103","author":"Voisard","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib21","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.CIR.91.7.1914","article-title":"Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells","volume":"91","author":"Weber","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bjs.4810","article-title":"Randomized clinical trial of the antiplatelet effects of aspirin\u2013clopidogrel combination versus aspirin alone after lower limb angioplasty","volume":"92","author":"Cassar","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.01.024","article-title":"Aspirin inhibits monocyte chemoattractant protein-1 and interleukin-8 expression in TNF-\u03b1 stimulated human umbilical vein endothelial cells","volume":"174","author":"Yang","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib25","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00041433-199912000-00010","article-title":"Low-density lipprotein-independent effects of statins","volume":"10","author":"Davignon","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11886-999-0027-7","article-title":"Non-lipid-lowering effects of statins on atherosclerosis","volume":"1","author":"Rosenson","year":"1999","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0735-1097(00)00771-3","article-title":"Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia","volume":"36","author":"Ferro","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.103.7.926","article-title":"Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization","volume":"103","author":"Crisby","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib31","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.ATV.0000148866.29829.19","article-title":"Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3\u2013Leiden transgenic mice","volume":"25","author":"Verschuren","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib33","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1161\/01.ATV.20.11.e101","volume":"20","author":"Cattaneo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib34","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1073\/pnas.0437879100","article-title":"Molecular bases of detective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding","volume":"100","author":"Cattaneo","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2006.11.006_bib35","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1538-7836.2003.00266.x","article-title":"Inherited platelet-based bleeding disorders","volume":"1","author":"Cattaneo","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(92)90445-O","article-title":"Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel","volume":"44","author":"Savi","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0038-1648859","article-title":"The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A","volume":"72","author":"Savi","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.12.4.430","article-title":"Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase","volume":"12","author":"Mills","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjcard.2003.11.048","article-title":"Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention","volume":"93","author":"Quinn","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2006.11.006_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin Pharmacol Ther"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006006769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T19:36:59Z","timestamp":1555961819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006006769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0021915006006769"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}